Cancer Institute A national cancer institute
designated cancer center

Heather Wakelee

Publication Details

  • Adjuvant chemotherapy of stage I non-small cell lung cancer in North America JOURNAL OF THORACIC ONCOLOGY Gandara, D. R., Wakelee, H., Calhoun, R., Jablons, D. 2007; 2 (7): S125-S127


    The utility of adjuvant chemotherapy after surgical resection for early-stage non-small cell lung cancer (NSCLC) is now well established. Although a number of randomized clinical trials have demonstrated the efficacy of platinum-based chemotherapy in the overall population treated, subset analysis, excepting Japanese studies, has uniformly shown the greatest efficacy for patients with stage II and III disease and the least benefit for patient with stage I disease. We review data regarding adjuvant therapy of stage I NSCLC from clinical trials performed in North America and Europe. Pertinent trials from Japan are discussed elsewhere in this issue.

    View details for Web of Science ID 000247937100007

    View details for PubMedID 17603308

Stanford Medicine Resources:

Footer Links: